Metaiodobenzylguanidine Imaging Comes of Age. A New Arrow in the Prognostic Quiver for Heart Failure Patients

Journal of the American College of Cardiology

Volumn 55, Issue 20, 2010, Pages 2222-2224

  Strauss, H William ^a   Johnson, Michelle N ^a   Schöder, Heiko ^a   Tamaki, Nagara ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

heart failure; meta iodobenzylguanidine; prognosis; radionuclide imaging; sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 123; GUANETHIDINE; NORADRENALIN;

ANALYTIC METHOD; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; CLINICAL TRIAL; COLLIMATOR; CONCENTRATION RESPONSE; DISEASE COURSE; DRUG CLEARANCE; DRUG UPTAKE; EDITORIAL; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART FUNCTION TEST; HEART MUSCLE; HEART TO MEDIASTINUM UPTAKE RATIO; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS I; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS II; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

3-IODOBENZYLGUANIDINE; HEART; HEART FAILURE; HUMANS; IODINE RADIOISOTOPES; MEDIASTINUM; MYOCARDIUM; PROGNOSIS; RADIOPHARMACEUTICALS;

EID: 77951936839     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.02.023     Document Type: Editorial

References (24)

1. Mann D.L. Pathophysiology of heart failure. In: Libby P., Bonow R.O., Mann D.L., and Zipes D.P. (Eds). Braunwald's Heart Disease. 8th edition (2008), WB Saunders, Philadelphia, PA 541-560
2. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., and Butler J. The sympathetic nervous system in heart failure. J Am Coll Cardiol 54 (2009) 1747-1762
3. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 307 (1982) 205-211
4. Backs J., Haunstetter A., Gerber S.H., et al. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol 33 (2001) 461-472
5. Beirwaltes W.H. Applications of I-131m-iodobenzylguanidine (MIBG). Nucl Med Biol 14 (1987) 183-189
6. Morales J.O., Beierwaltes W.H., Counsell R.E., and Meier D.E. The concentration of radioactivity from labeled epinephrine and its precursors in the dog adrenal medulla. J Nucl Med 8 (1967) 800-809
7. McEwan A.J., Shapiro B., Sisson J.C., Beirwaltes W.H., and Ackery D.M. Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 15 (1985) 132-153
8. Schanker L.S., and Morrison A.S. Physiological disposition of guanethidine in the rat and its uptake by heart slices. Int J Neuropharmacol 4 (1965) 27-39
9. Wieland D.M., Wu J.L., Brown L.E., Mangner T.J., Swanson D.P., and Beierwaltes W.M. Radiolabeled adrenergic neuron blocking agents: adrenomedullary imaging with [13l]iodobenzylguanidine. J Nucl Med 21 (1980) 349-353
10. Wieland D.M., Brown L.E., Rogers W.H., et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22 (1981) 22-31
11. Kline R.C., Swanson D.P., Wieland D.M., et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22 (1981) 129-132
12. Manger W.M., and Hoffman B.B. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake [teaching editorial]. J Nucl Med 24 (1983) 1194-1196
13. Tobes M.C., Jacques S., Wieland D.M., and Sisson J.C. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 26 (1985) 897-907
14. Carrio I., Flotats A., Estorch M., and Camacho V. Cardiac neurotransmission imaging: single photon emission computed tomography. In: Zaret B.L., and Beller G.M. (Eds). Clinical Nuclear Cardiology. 3rd edition (2005), Elsevier Mosby, Philadelphia, PA 577-591
15. Kolby L., Bernhardt P., Levin-Jakobsen A.M., et al. Uptake of metaiodobenzylguanidine in neuroendocrine tumors is mediated by vesicular monoamine transporters. Br J Cancer 89 (2003) 1383-1388
16. Nakajo M., Shimabukuro K., Yoshimura H., et al. Iodine-131 metaiodibenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 27 (1986) 84-89
17. 131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure. Circ Res 61 (1987) 797-804
18. Henderson E.B., Kahn J.K., Corbett J.R., et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78 (1988) 1192-1199
19. Tanaka T., Aizawa T., Kato K., et al. Estimation of regional myocardial sympathetic neuronal function with I-123 metaiodobenzylguanidine (MIBG) myocardial images in patients with cardiomyopathy. Kaku Igaku 26 (1989) 257-261
20. Merlet P., Valette H., Dubois-Rande J.L., et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33 (1992) 471-477
21. Tamaki S., Yamada T., Okuyama Y., et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction inpatients with chronic heart failure and left ventricular dysfunction. J Am Coll Cardiol 53 (2009) 426-435
22. Tsuchimochi S., Tamaki N., Tadamura E., et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by I-123 MIBG imaging. J Nucl Med 36 (1995) 969-974
23. Agostini D., Carrio I., and Verberne H.J. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging 36 (2009) 555-559
24. Jacobson A.F., Senior R., Cerqueira M.D., et al., ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55 (2010) 2212-2221